Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-238.09M
↓ 121% below average
Average (9y)
$-107.63M
Historical baseline
Range
High:$-10.07M
Low:$-238.09M
CAGR
+42.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-238.09M | -41.3% |
| 2023 | $-168.46M | +3.3% |
| 2022 | $-174.25M | -154.5% |
| 2021 | $-68.45M | +49.6% |
| 2020 | $-135.88M | +6.4% |
| 2019 | $-145.17M | -86.2% |
| 2018 | $-77.97M | -142.2% |
| 2017 | $-32.19M | -25.0% |
| 2016 | $-25.76M | -155.7% |
| 2015 | $-10.07M | - |